Levim Biotech

Chennai, India
Develops therapeutic recombinant proteins and drug delivery systems for healthcare applications.
Annual revenue $1.7M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Levim Biotech

Levim Biotech is a company based in Chennai (India) by Nitin Vimal and Jatin Vimal. It operates as a B2B. Levim Biotech operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, Arrakis Therapeutics, MyoKardia and Eiger BioPharmaceuticals, among others.

  • Headquarter Chennai, India
  • Founders Nitin Vimal, Jatin Vimal
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.65 M (USD)
    0
    as on Mar 31, 2023
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Levim Biotech

Premium access

Detailed funding history for Levim Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Levim Biotech

Investments
Premium access

Investment portfolio details for Levim Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Levim Biotech

Premium access

Detailed financials for Levim Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Levim Biotech Comparisons

Levim Biotech Primary company
Description
Develops therapeutic recombinant proteins and drug delivery ...
Location
Chennai, India
Founded Year
-
Annual Revenue
$1.65 M (USD)
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Levim Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Levim Biotech

Levim Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, Arrakis Therapeutics, MyoKardia and Eiger BioPharmaceuticals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Regenerative and gene therapeutics for heart failure are developed.
Locked Locked Locked
Developer of autologous cell therapies
Locked Locked Locked
Provider of tools for the analysis of RNA structures
Locked Locked Locked
Specialized drugs are developed for genetic heart diseases.
Locked Locked Locked
Developer of antiviral agents against targets in the treatment of hepatitis
Locked Locked Locked
Therapeutics for heart and cardiovascular diseases are developed.
Premium access

Detailed competitors of Levim Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Levim Biotech

Premium access

Complete news archive for Levim Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Levim Biotech

Levim Biotech is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Jatin Vimal is the current CEO of Levim Biotech. They have also founded this company.

Annual revenue of Levim Biotech is $1.65M as on Mar 31, 2023.

Levim Biotech develops therapeutic recombinant proteins and drug delivery systems for healthcare applications through providing healthcare solutions, advancing biotech innovations, therapeutics, and drug delivery. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Levim Biotech's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available